Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blüthgen, Nils (1) Daumke, Oliver Prof. Dr. (1) Gavvovidis, Ioannis Dr. (1) Hinz, Michael Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Dr. (4) Lorenz, Felix Dr. (1) Mastrobuoni, Guido Dr. (1) Obenaus, Matthias (1) Rhein, Simone Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmidt-Ullrich, Ruth Dr. (5) Schütz, Anja Dr. (1) Uckert, Wolfgang Prof. Dr. (10) Wolf, Jana Prof. Dr. (1) Wollert-Wulf, Brigitte (1) Wyler, Emanuel Dr. (1) Yilmaz, Zekiye Buket Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (3) (-) Heinemann, Udo Prof. Dr. (1) (-) Janz, Martin Dr. (4) (-) Mathas, Stephan Dr. (9) (-) Müller, Gerd Dr. (1) 1998 (2) 1999 (1) 2000 (3) 2001 (1) 2002 (5) 2003 (7) 2004 (4) 2005 (6) 2006 (6) 2007 (5) (-) 2008 (5) 2009 (4) 2010 (4) 2011 (6) 2012 (2) 2013 (3) 2014 (3) (-) 2015 (9) 2016 (4) 2017 (6) 2018 (1) 2019 (3) 2020 (6) 2021 (3) 2022 (7) (-) Biology of Malignant Lymphomas (9) Immune Regulation and Cancer (1) Light Microscopy (BIMSB) (2) Macromolecular Structure and Interaction (9) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) (-) Molecular Cell Biology and Gene Therapy (3) Molecular Immunology and Gene Therapy (8) Proteomics Metabolomics (1) RNA Biology and Posttranscriptional Regulation (1) Signal Transduction in Development and Cancer (1) (-) Signal Transduction in Tumor Cells (2) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) Translational Oncology of Solid Tumors (1) 14 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Heinemann, Udo Prof. Dr.Janz, Martin Dr.Mathas, Stephan Dr.Müller, Gerd Dr.Biology of Malignant LymphomasMolecular Cell Biology and Gene TherapySignal Transduction in Tumor Cells20082015 Sort: Result score Newest to oldest Oldest to newest August 01, 2015 in Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp July 14, 2015 in Nat Commun RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway Y. Murakawa M. Hinz J. Mothes A. Schuetz M. Uhl E. Wyler T. Yasuda G. Mastrobuoni C.C. Friedel L. Dölken S. Kempa M. Schmidt-Supprian N. Blüthgen R. Backofen U. Heinemann J. Wolf C. Scheidereit M. Landthaler June 01, 2015 in Front Biosci The origins of ALK translocations V. Roukos S. Mathas May 01, 2015 in Leukemia The IL-15 cytokine system provides growth and survival signals in hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells K. Ullrich F. Blumenthal-Barby B. Lamprecht K. Koechert D. Lenze M. Hummel S. Mathas B. Doerken M. Janz April 11, 2015 in Lancet Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial K. Behringer H. Goergen F. Hitz J.M. Zijlstra R. Greil J. Markova S. Sasse M. Fuchs M.S. Topp M. Soekler S. Mathas J. Meissner M. Wilhelm P. Koch H.W. Lindemann E. Schalk R. Semrau J. Kriz T. Vieler M. Bentz E. Lange R. Mahlberg A. Hassler M. Vogelhuber D. Hahn J. Mezger S.W. Krause N. Skoetz B. Böll B. von Tresckow V. Diehl M. Hallek P. Borchmann H. Stein H. Eich A. Engert April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein March 01, 2015 in Cytokine Cytokine and proinflammatory gene expression in classical Hodgkin lymphoma: its more than NF-κB! S. Kreher P. Cauchy C. Bonifer S. Mathas January 01, 2015 in Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz December 01, 2008 in Leukemia Notch inhibition blocks multiple myeloma cell-induced osteoclast activation R. Schwarzer M. Kaiser O. Acikgoez U. Heider S. Mathas R. Preissner O. Sezer B. Doerken F. Jundt Pagination Current page 1 Page 2 Next page Next › Last page Last »
August 01, 2015 in Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp
July 14, 2015 in Nat Commun RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway Y. Murakawa M. Hinz J. Mothes A. Schuetz M. Uhl E. Wyler T. Yasuda G. Mastrobuoni C.C. Friedel L. Dölken S. Kempa M. Schmidt-Supprian N. Blüthgen R. Backofen U. Heinemann J. Wolf C. Scheidereit M. Landthaler
May 01, 2015 in Leukemia The IL-15 cytokine system provides growth and survival signals in hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells K. Ullrich F. Blumenthal-Barby B. Lamprecht K. Koechert D. Lenze M. Hummel S. Mathas B. Doerken M. Janz
April 11, 2015 in Lancet Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial K. Behringer H. Goergen F. Hitz J.M. Zijlstra R. Greil J. Markova S. Sasse M. Fuchs M.S. Topp M. Soekler S. Mathas J. Meissner M. Wilhelm P. Koch H.W. Lindemann E. Schalk R. Semrau J. Kriz T. Vieler M. Bentz E. Lange R. Mahlberg A. Hassler M. Vogelhuber D. Hahn J. Mezger S.W. Krause N. Skoetz B. Böll B. von Tresckow V. Diehl M. Hallek P. Borchmann H. Stein H. Eich A. Engert
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
March 01, 2015 in Cytokine Cytokine and proinflammatory gene expression in classical Hodgkin lymphoma: its more than NF-κB! S. Kreher P. Cauchy C. Bonifer S. Mathas
January 01, 2015 in Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz
December 01, 2008 in Leukemia Notch inhibition blocks multiple myeloma cell-induced osteoclast activation R. Schwarzer M. Kaiser O. Acikgoez U. Heider S. Mathas R. Preissner O. Sezer B. Doerken F. Jundt
